Evidence map›Paper›PMID 42644009›Full record

ArticlePCN reports : psychiatry and clinical neurosciences2026

Catatonia with prominent psychosocial factors: A case report.

Hiroto Noguchi, Yuki Omiya, Masahiro Hishiyama, Mariko Nakau, Sadayuki Hashioka

Abstract read
In one paragraph

Article in PCN reports : psychiatry and clinical neurosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Catatonia with prominent psychosocial factors: A case report.PCN reports : psychiatry and clinical neurosciences · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hiroto NoguchiDepartment of Psychiatry Asahikawa Medical University Asahikawa Hokkaido Japan.ORCID https://orcid.org/0009-0005-6415-4003
Yuki OmiyaDepartment of Psychiatry Asahikawa Medical University Asahikawa Hokkaido Japan.ORCID https://orcid.org/0000-0002-4155-4160
Masahiro HishiyamaDepartment of Psychiatry Asahikawa Medical University Asahikawa Hokkaido Japan.
Mariko NakauDepartment of Psychiatry Asahikawa Medical University Asahikawa Hokkaido Japan.
Sadayuki HashiokaDepartment of Psychiatry Asahikawa Medical University Asahikawa Hokkaido Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Catatonia is a psychomotor syndrome historically linked to schizophrenia but now recognized across diverse psychiatric, medical, and psychosocial contexts. Detailed reports of catatonia arising amid pronounced psychosocial vulnerability remain scarce. We describe catatonia in a patient with co-occurring somatic symptom disorder, functional neurological symptom disorder (FNSD), and dissociative disorder that remitted with pharmacotherapy. Case Presentation: A man in his 40's with chronic physical illness and recurrent fears of abandonment by his partner developed functional and dissociative symptoms after his partner's surgery was scheduled and was admitted following the sudden onset of fragmented, childlike speech. No specific neurological or medical cause was identified, and no schizophrenia or mood disorder was present. He developed stupor, mutism, posturing, negativism, mannerisms, and stereotypy, meeting DSM-5-TR criteria for catatonia; the Bush-Francis Catatonia Rating Scale (BFCRS) score was 22. Under lorazepam 3 mg/day and quetiapine 600 mg/day, the BFCRS improved to 3 by hospital Day 34, but worsened during dose reduction of either drug and improved on re-escalation. He was discharged on hospital Day 98 with a BFCRS of 0, with no recurrence at 10 months. Conclusion: Catatonia can arise in patients with co-occurring somatic symptom disorder, FNSD, and dissociative disorder. In this patient, catatonia showed dose-dependent re-emergence during tapering of both lorazepam and quetiapine, with remission on re-escalation. Even when psychosocial factors appear prominent, careful monitoring and gradual dose adjustment may be important for maintaining remission.

Indexed as

catatoniadissociative disordersfunctional neurological symptom disorderpharmacotherapypsychosocial stress

Identifiers

PMID42644009
PMCPMC13504668

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.